Inventor · disambiguated record
Paul Olson
Also filed as: OLSON PAUL · OLSON PAUL K
14 granted patents·18 pending applications·229 citations·filing 1997–2020
93Inventor score
Files withAPELLIS PHARMACEUTICALS INC6FRANCOIS CEDRIC6POTENTIA PHARMACEUTICALS INC6KYPHA INC4DESCHATELETS PASCAL3
Top patents by PatentIndex Score
32 records- 0196US8580735B2Local complement inhibition for treatment of complement-mediated disordersFRANCOIS CEDRIC·Filed 2008·Granted Nov 12, 2013·50 cites·21 claims
- 0295US9056076B2Method of treating age-related macular degeneration comprising administering a compstatin analogDESCHATELETS PASCAL·Filed 2012·Granted Jun 16, 2015·39 cites·19 claims
- 0395US8168584B2Methods of treating age-related macular degeneration by compstatin and analogs thereofDESCHATELETS PASCAL·Filed 2006·Granted May 1, 2012·44 cites·58 claims
- 0494US10407466B2Methods of selecting compstatin mimeticsAPELLIS PHARMACEUTICALS INC·Filed 2017·Granted Sep 10, 2019·12 cites·2 claims
- 0592US8043609B2Viral complement control proteins for eye disordersPOTENTIA PHARMACEUTICALS INC·Filed 2006·Granted Oct 25, 2011·14 cites·14 claims
- 0690US7947267B2Viral complement control proteins for eye disordersPOTENTIA PHARMACEUTICALS INC·Filed 2005·Granted May 24, 2011·19 cites·59 claims
- 0789US9291622B2Complement assays and uses thereofZHANG ZHOUNING·Filed 2010·Granted Mar 22, 2016·24 cites·20 claims
- 0880US8198020B2Compositions and methods for enhancing phagocytosis or phagocyte activityFRANCOIS CEDRIC·Filed 2004·Granted Jun 12, 2012·17 cites·59 claims
- 0977US9164088B2Detecting complement activationKYPHA INC·Filed 2014·Granted Oct 20, 2015·4 cites·30 claims
- 1074US8865164B2Detecting complement activationOLSON PAUL·Filed 2012·Granted Oct 21, 2014·3 cites·9 claims
- 1169US9182396B2Lateral flow immunoassay for complement activation and methods of use for point-of-care assessment of complement-associated disordersOLSON PAUL·Filed 2011·Granted Nov 10, 2015·2 cites·28 claims
- 1266US9939446B2Lateral flow immunoassay for complement activation and methods of use for point-of-care assessment of complement-associated disordersKYPHA INC·Filed 2015·Granted Apr 10, 2018·1 cites·19 claims
- 1362US2015150945A1Modifying Macrophage Phenotype for Treatment of DiseaseAPELLIS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1460US2009220572A1Injectable Combination Therapy for Eye DisordersPOTENTIA PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 1559US2020172908A1Nanocomposites for imaging and drug deliveryMicrovascular Therapeutics LLC·Filed 2020·Application pending·0 cites
- 1658US2006257359A1Modifying macrophage phenotype for treatment of diseaseFRANCOIS CEDRIC·Filed 2006·Application pending·0 cites
- 1757US2011092446A1Compositions and methods for treatment of traumaFRANCOIS CEDRIC·Filed 2008·Application pending·0 cites
- 1857US2018000899A1Modifying macrophage phenotype for treatment of diseaseAPELLIS PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1956US2014050739A1Local complement inhibition for treatment of complement-mediated disordersAPELLIS PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2055US2012225114A1Modifying Macrophage Phenotype for Treatment of DiseaseFRANCOIS CEDRIC·Filed 2011·Application pending·0 cites
- 2155US2015250898A1Nanocomposites for imaging and drug deliveryNUVOX PHARMA LLC·Filed 2013·Application pending·0 cites
- 2254US2016015810A1Injectable combination therapy for eye disordersPOTENTIA PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 2354US2018333488A1Local complement inhibition for treatment of complement-mediated disordersAPELLIS PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 2454US2016060297A1Compstatin and analogs thereof for eye disordersPOTENTIA PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 2554US2013072442A1Viral Complement Control Proteins for Eye DisordersDESCHATELETS PASCAL·Filed 2011·Application pending·0 cites
- 2651US2011190221A1Modulation and repletion/enhancement of the complement system for treatment of traumaAPELLIS AG·Filed 2009·Application pending·0 cites
- 2749US2011182877A1Sustained delivery of compstatin analogs from gelsPOTENTIA PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 2846US2016153985A1Complement assays and uses thereofAPELLIS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2944US2016084833A1Detecting complement activationKYPHA INC·Filed 2015·Application pending·0 cites
- 3043US2009117171A1Compositions and methods for treatment of macular degeneration and related conditionsFRANCOIS CEDRIC·Filed 2006·Application pending·0 cites
- 3135US11029318B2Methods for predicting and treating patients with increased risk of adverse pregnancy outcomeKYPHA INC·Filed 2016·Granted Jun 8, 2021·0 cites·12 claims
- 3227US6200750B1Mammalian homologous recombination activating sequences and method of identification and their use thereofUNIV JEFFERSON·Filed 1997·Granted Mar 13, 2001·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Paul Olson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →